| UniProt ID | ENAH_MOUSE | |
|---|---|---|
| UniProt AC | Q03173 | |
| Protein Name | Protein enabled homolog | |
| Gene Name | Enah | |
| Organism | Mus musculus (Mouse). | |
| Sequence Length | 802 | |
| Subcellular Localization | Cytoplasm . Cytoplasm, cytoskeleton. Cell projection, lamellipodium. Cell projection, filopodium. Cell junction, synapse. Cell junction, focal adhesion. Targeted to the leading edge of lamellipodia and filopodia by MRL family members. Colocalizes at | |
| Protein Description | Ena/VASP proteins are actin-associated proteins involved in a range of processes dependent on cytoskeleton remodeling and cell polarity such as axon guidance and lamellipodial and filopodial dynamics in migrating cells. ENAH induces the formation of F-actin rich outgrowths in fibroblasts. Acts synergistically with BAIAP2-alpha and downstream of NTN1 to promote filipodia formation.. | |
| Protein Sequence | MSEQSICQARAAVMVYDDANKKWVPAGGSTGFSRVHIYHHTGNNTFRVVGRKIQDHQVVINCAIPKGLKYNQATQTFHQWRDARQVYGLNFGSKEDANVFASAMMHALEVLNSQEAAQSKVTATQDSTNLRCIFCGPTLPRQNSQLPAQVQNGPSQEELEIQRRQLQEQQRQKELERERMERERLERERLERERLERERLEQEQLERQRQEREHVERLERERLERLERERQERERERLEQLEREQVEWERERRMSNAAPSSDSSLSSAPLPEYSSCQPPSAPPPSYAKVISAPVSDATPDYAVVTALPPTSTPPTPPLRHAATRFATSLGSAFHPVLPHYATVPRPLNKNSRPSSPVNTPSSQPPAAKSCAWPTSNFSPLPPSPPIMISSPPGKATGPRPVLPVCVSSPVPQMPPSPTAPNGSLDSVTYPVSPPPTSGPAAPPPPPPPPPPPPPPPLPPPPLPPLASLSHCGSQASPPPGTPLASTPSSKPSVLPSPSAGAPASAETPLNPELGDSSASEPGLQAASQPAESPTPQGLVLGPPAPPPPPPLPSGPAYASALPPPPGPPPPPPLPSTGPPPPPPPPPPLPNQAPPPPPPPPAPPLPASGIFSGSTSEDNRPLTGLAAAIAGAKLRKVSRVEDGSFPGGGNTGSVSLASSKADAGRGNGPLPLGGSGLMEEMSALLARRRRIAEKGSTIETEQKEDRNEDAEPITAKAPSTSTPEPTRKPWERTNTMNGSKSPVISRPKSTPSSQPSANGVQTEGLDYDRLKQDILDEMRKELAKLKEELIDAIRQELSKSNTA | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 69 | Ubiquitination | CAIPKGLKYNQATQT EEECCCCCCCHHHCC | 51.31 | - | |
| 125 (in isoform 6) | Phosphorylation | - | 39.95 | 29514104 | |
| 125 (in isoform 3) | Phosphorylation | - | 39.95 | 29514104 | |
| 125 (in isoform 4) | Phosphorylation | - | 39.95 | 29514104 | |
| 144 | Phosphorylation | PTLPRQNSQLPAQVQ CCCCCCCCCCCHHHH | 25.42 | 25521595 | |
| 255 | Phosphorylation | WERERRMSNAAPSSD HHHHHHHHCCCCCCC | 22.85 | 26643407 | |
| 260 | Phosphorylation | RMSNAAPSSDSSLSS HHHCCCCCCCCCCCC | 41.89 | 26643407 | |
| 261 | Phosphorylation | MSNAAPSSDSSLSSA HHCCCCCCCCCCCCC | 40.22 | 26643407 | |
| 263 | Phosphorylation | NAAPSSDSSLSSAPL CCCCCCCCCCCCCCC | 34.82 | 26643407 | |
| 264 | Phosphorylation | AAPSSDSSLSSAPLP CCCCCCCCCCCCCCC | 36.94 | 26643407 | |
| 266 | Phosphorylation | PSSDSSLSSAPLPEY CCCCCCCCCCCCCCC | 26.80 | 26643407 | |
| 292 (in isoform 3) | O-linked_Glycosylation | - | 9.44 | 22517741 | |
| 293 (in isoform 4) | O-linked_Glycosylation | - | 21.25 | 22517741 | |
| 310 | Phosphorylation | VVTALPPTSTPPTPP EEEECCCCCCCCCCC | 43.20 | 26643407 | |
| 311 | Phosphorylation | VTALPPTSTPPTPPL EEECCCCCCCCCCCH | 44.69 | 26643407 | |
| 312 | Phosphorylation | TALPPTSTPPTPPLR EECCCCCCCCCCCHH | 35.45 | 26643407 | |
| 315 | Phosphorylation | PPTSTPPTPPLRHAA CCCCCCCCCCHHHHH | 38.45 | 29899451 | |
| 327 | Phosphorylation | HAATRFATSLGSAFH HHHHHHHHHHHHHHC | 23.05 | - | |
| 328 | Phosphorylation | AATRFATSLGSAFHP HHHHHHHHHHHHHCC | 27.57 | - | |
| 351 | Phosphorylation | PRPLNKNSRPSSPVN CCCCCCCCCCCCCCC | 47.37 | 25521595 | |
| 354 | Phosphorylation | LNKNSRPSSPVNTPS CCCCCCCCCCCCCCC | 46.28 | 25521595 | |
| 355 | Phosphorylation | NKNSRPSSPVNTPSS CCCCCCCCCCCCCCC | 35.23 | 25521595 | |
| 359 | Phosphorylation | RPSSPVNTPSSQPPA CCCCCCCCCCCCCCC | 25.45 | 25521595 | |
| 361 | Phosphorylation | SSPVNTPSSQPPAAK CCCCCCCCCCCCCHH | 39.30 | 24925903 | |
| 362 | Phosphorylation | SPVNTPSSQPPAAKS CCCCCCCCCCCCHHC | 48.16 | 24925903 | |
| 362 | O-linked_Glycosylation | SPVNTPSSQPPAAKS CCCCCCCCCCCCHHC | 48.16 | 22517741 | |
| 374 | Phosphorylation | AKSCAWPTSNFSPLP HHCCCCCCCCCCCCC | 26.12 | 26643407 | |
| 375 | Phosphorylation | KSCAWPTSNFSPLPP HCCCCCCCCCCCCCC | 31.62 | 26643407 | |
| 378 | Phosphorylation | AWPTSNFSPLPPSPP CCCCCCCCCCCCCCC | 29.76 | 26643407 | |
| 383 | Phosphorylation | NFSPLPPSPPIMISS CCCCCCCCCCEEEEC | 41.17 | 26643407 | |
| 389 | Phosphorylation | PSPPIMISSPPGKAT CCCCEEEECCCCCCC | 21.29 | 26643407 | |
| 390 | Phosphorylation | SPPIMISSPPGKATG CCCEEEECCCCCCCC | 24.96 | 26643407 | |
| 557 | Phosphorylation | PLPSGPAYASALPPP CCCCCCCCCCCCCCC | 12.29 | 12672821 | |
| 637 | Phosphorylation | GAKLRKVSRVEDGSF HCEECEEEEECCCCC | 33.37 | 25521595 | |
| 643 | Phosphorylation | VSRVEDGSFPGGGNT EEEECCCCCCCCCCC | 40.36 | 26239621 | |
| 650 | Phosphorylation | SFPGGGNTGSVSLAS CCCCCCCCCCEEEEC | 33.82 | 25266776 | |
| 652 | Phosphorylation | PGGGNTGSVSLASSK CCCCCCCCEEEECCC | 13.39 | 26643407 | |
| 654 | Phosphorylation | GGNTGSVSLASSKAD CCCCCCEEEECCCCC | 21.66 | 26643407 | |
| 664 | Methylation | SSKADAGRGNGPLPL CCCCCCCCCCCCCCC | 36.80 | - | |
| 695 | Phosphorylation | RRIAEKGSTIETEQK HHHHHHCCCCHHHCC | 36.96 | 26239621 | |
| 696 | Phosphorylation | RIAEKGSTIETEQKE HHHHHCCCCHHHCCC | 31.34 | 26824392 | |
| 699 | Phosphorylation | EKGSTIETEQKEDRN HHCCCCHHHCCCCCC | 39.61 | 26643407 | |
| 701 (in isoform 4) | O-linked_Glycosylation | - | 62.95 | 22517741 | |
| 702 (in isoform 4) | O-linked_Glycosylation | - | 56.18 | 22517741 | |
| 718 | Phosphorylation | PITAKAPSTSTPEPT CCCCCCCCCCCCCCC | 39.59 | 26239621 | |
| 719 | Phosphorylation | ITAKAPSTSTPEPTR CCCCCCCCCCCCCCC | 35.24 | 23737553 | |
| 720 | Phosphorylation | TAKAPSTSTPEPTRK CCCCCCCCCCCCCCC | 46.43 | 23737553 | |
| 721 | Phosphorylation | AKAPSTSTPEPTRKP CCCCCCCCCCCCCCC | 31.59 | 25521595 | |
| 725 | Phosphorylation | STSTPEPTRKPWERT CCCCCCCCCCCCCCC | 50.06 | 28066266 | |
| 732 | Phosphorylation | TRKPWERTNTMNGSK CCCCCCCCCCCCCCC | 24.43 | 24759943 | |
| 734 | Phosphorylation | KPWERTNTMNGSKSP CCCCCCCCCCCCCCC | 16.05 | 27742792 | |
| 738 | Phosphorylation | RTNTMNGSKSPVISR CCCCCCCCCCCCCCC | 25.59 | 27742792 | |
| 740 | Phosphorylation | NTMNGSKSPVISRPK CCCCCCCCCCCCCCC | 26.54 | 25521595 | |
| 744 | Phosphorylation | GSKSPVISRPKSTPS CCCCCCCCCCCCCCC | 42.64 | 26745281 | |
| 748 | Phosphorylation | PVISRPKSTPSSQPS CCCCCCCCCCCCCCC | 48.51 | 27087446 | |
| 749 | Phosphorylation | VISRPKSTPSSQPSA CCCCCCCCCCCCCCC | 33.06 | 27087446 | |
| 751 | Phosphorylation | SRPKSTPSSQPSANG CCCCCCCCCCCCCCC | 41.51 | 25293948 | |
| 752 | Phosphorylation | RPKSTPSSQPSANGV CCCCCCCCCCCCCCC | 47.52 | 25293948 | |
| 755 | Phosphorylation | STPSSQPSANGVQTE CCCCCCCCCCCCCCC | 27.08 | 25293948 | |
| 785 | Acetylation | RKELAKLKEELIDAI HHHHHHHHHHHHHHH | 48.73 | 22826441 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 236 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
| 255 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
| 255 | S | Phosphorylation | Kinase | PKA | - | Uniprot |
| 296 | Y | Phosphorylation | Kinase | ABL1 | P00520 | GPS |
| 296 | Y | Phosphorylation | Kinase | ABL-FAMILY | - | GPS |
| Modified Location | Modified Residue | Modification | Function | Reference |
|---|---|---|---|---|
| 255 | S | Phosphorylation |
| 12134088 |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ENAH_MOUSE !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| ABL1_MOUSE | Abl1 | physical | 8861907 | |
| SRC_MOUSE | Src | physical | 8861907 | |
| FYN_MOUSE | Fyn | physical | 8861907 | |
| ZYX_MOUSE | Zyx | physical | 8861907 | |
| VINC_MOUSE | Vcl | physical | 8861907 | |
| PROF1_MOUSE | Pfn1 | physical | 8861907 | |
| TRIM9_MOUSE | Trim9 | physical | 26702829 |
| Kegg Drug | ||||||
|---|---|---|---|---|---|---|
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Critical role of Ena/VASP proteins for filopodia formation in neuronsand in function downstream of netrin-1."; Lebrand C., Dent E.W., Strasser G.A., Lanier L.M., Krause M.,Svitkina T.M., Borisy G.G., Gertler F.B.; Neuron 42:37-49(2004). Cited for: FUNCTION, AND PHOSPHORYLATION AT SER-255. | |
| "Phosphoproteomic analysis of the developing mouse brain."; Ballif B.A., Villen J., Beausoleil S.A., Schwartz D., Gygi S.P.; Mol. Cell. Proteomics 3:1093-1101(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-144, AND MASSSPECTROMETRY. | |
| "Abl interactor 1 promotes tyrosine 296 phosphorylation of mammalianenabled (Mena) by c-Abl kinase."; Tani K., Sato S., Sukezane T., Kojima H., Hirose H., Hanafusa H.,Shishido T.; J. Biol. Chem. 278:21685-21692(2003). Cited for: ALTERNATIVE SPLICING (ISOFORM 6), PHOSPHORYLATION AT TYR-557, ANDINTERACTION WITH ABI1. | |